Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C2 | P08235 | 1/20 | 0.31 |
| ▸ | PIP4K2C | Q8TBX8 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21250118 | 0.81 | SCN8A (0.34) | PIP4K2CACHE | |
| SCHEMBL26061532 | 0.69 | TRPM8 (0.34) | — | |
| SCHEMBL18812906 | 0.67 | CXCR4 (0.33) | — | |
| SCHEMBL21675599 | 0.67 | ESR1 (0.37) | — | |
| SCHEMBL23790646 | 0.67 | CXCR4 (0.36) | ACHE | |
| SCHEMBL21686632 | 0.66 | PARP1 (0.34) | — | |
| SCHEMBL21250137 | 0.65 | ESR1 (0.32) | — | |
| SCHEMBL18427396 | 0.65 | SMN1; SMN2 (0.38) | — | |
| SCHEMBL19646227 | 0.65 | SMN1; SMN2 (0.38) | — | |
| SCHEMBL19545352 | 0.64 | HTR2A (0.37) | NR3C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210009557-A1 | ACYCLIC CXCR4 INHIBITORS AND USES THEREOF | X4 PHARMACEUTICALS, INC. | 2021-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210009557-A1 | ACYCLIC CXCR4 INHIBITORS AND USES THEREOF | CXCR4, CXCR3, CXCR1 | NR3C2 392/4885PIP4K2C 616/4885ACHE 4764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.